Mr Doctor connects medical professionals with properly paid* market research opportunities.

Pricing a Device: A 10-Minute Survey of Venous Specialists

The right price depends on who you ask. So the screener did a lot of the work.

A device maker wanted to know what US physicians would pay for a dedicated deep venous crossing device, using two prototype concepts as benchmarks. It also wanted to understand current crossing practice.

That meant reaching physicians who cross…

Front Line, Not Specialty: Measuring Brand Awareness Where Patients Ask First

Interviews and a survey of 180 family physicians and GPs in the US and Europe provided a pharmaceutical client with a baseline of primary care awareness of anti-diabetic weight-loss brands and showed where its communication could be strengthened.

A pharmaceutical company wanted to understand how primary care physicians perceive anti-diabetic medications used for…

Reaching Schizophrenia Lead Clinicians

Fifteen interviews with regional lead psychiatrists revealed how schizophrenia care shifts across settings and how best to reach the clinicians who shape it.

A pharmaceutical company wanted to understand how UK psychiatrists treat the positive and negative symptoms of schizophrenia, how they trial new drugs, and which channels reach them best.

Rather than a broad sample, the recruiter focused on…

Testing Aortic Messaging at Congress: 41 Interviews in Germany and Miami

Recruiting and researching at congresses provides the best chance to quickly and efficiently capture a true cross-section of physicians: ideal for Europe.

A manufacturer needed to finalize launch messaging for a new abdominal aortic stent-graft, as well as campaign messaging for its established device and broader aortic portfolio. The same interviews also explored…

Same Device, Different Hands: Testing Embolic Protection in TAVR and TEVAR

A single-device concept was being considered for two very different procedures, each carried out by a different specialist. To get useful feedback, the recruit had to cover both.

A manufacturer was developing a single-vessel cerebral embolic protection device and wanted to understand where it might fit during transcatheter aortic valve replacement (TAVR) and…

Ask About the Last Case: Recruiting EVAR Physicians for Real, Recent Experience

Ask a physician how they usually plan a case and you get the textbook answer. Ask them to walk you through their last one and you get what actually happened.

A manufacturer wanted to map how US physicians plan standard abdominal aortic aneurysm repair with EVAR: from requesting CT images to measurements…

Mapping a Rare Disease Pathway

Recruiting through established networks.

The client was preparing for a new adult indication in X-linked hypophosphatemia (XLH), a rare inherited condition. It needed to understand how adult patients move through the UK health system: who sees them first, who diagnoses them, and who manages them long term.

Adult XLH care in the UK is spread across several specialties, so…

Testing demand for a next-generation aortic stent-graft alongside its predecessor in London, Chicago, and New York

Some questions can't be answered from a screen. Physicians need to see and handle the device.

A manufacturer planned to launch a next-generation aortic stent-graft while keeping its established version on the market. It needed to know whether physicians saw value in having both.

Each one-hour structured interview…

Recruiting RA Patients Who Reflect Real Life: Quotas for a Five-City Needs Study

Two quotas ensured the sample reflected how RA affects working life and that well-controlled patients didn't skew it towards mild.

A pharmaceutical company wanted to understand the needs of people with rheumatoid arthritis (RA) to guide planning for its immunology pipeline, including which patient types might benefit most from new options…

Will a Next-Generation Stent Graft Change Practice? Asking High and Low Users at VEITH

By interviewing both heavy and light users of the current device, we estimated how far a next-generation version could shift treatment choices.

A manufacturer wanted to validate the scope of a next-generation balloon-expandable covered stent graft and judge whether it would shift treatment choices in aortoiliac occlusive disease and complex…

Quotas by Brand: Building a Sample That Knows Every Venous Stent

To map a competitive landscape, you need physicians who have used the competition.

A manufacturer entering the venous stent market wanted to see how its device would stack up against the competition and what physicians valued most.

The recruit had two layers of quotas.

First, specialty and region. The target was 40 physicians…

Mapping the Heart Failure Referral Pathway, from Transplant Center to Private Practice

A cardiologist's practice setting shapes how they view advanced heart failure therapy and whether they refer for it.

A company developing a partial-support mechanical circulatory support device wanted to understand how US cardiologists would view it and where it might fit in the referral pathway.

The recruit was designed to cover the…

Reading the Label in the Field: Testing Vaccine Labeling With Community Nurses

A vaccine label has to work in a busy clinic, not just on a design screen.

A client wanted to understand how vaccine labels perform in everyday use. The key questions were whether information is easy to find and read, where mistakes could happen, and which changes would make labels clearer.

Community…

Qual / Quant: Mapping the Portal Hypertension Patient Referral Pathway

Talking to referrers first made sure a 201-physician survey asked the right questions.

A manufacturer wanted to understand how US patients with portal hypertension move through the health system and where a type of portal hypertension surgery fits in the treatment pathway. The focus was on referrers, the physicians who decide whether a patient…

Sizing the Visceral Aortic Market: 345 Specialists, Four Regions, One Survey

Sizing a market requires a sample with reach, and this one exceeded the target in every region.

A manufacturer developing a device for aneurysms near or involving the renal arteries wanted to know whether the visceral segment is worth investing in and how to segment it.

The answer called for a quantitative read…

24 Physicians, Three Markets, One Clear Read on Large-Bore Concepts

A balanced, in-person recruit made cross-market comparison simple.

A manufacturer wanted to test new concepts for its large-bore sheath and gauge reactions to two large-bore closure device concepts. It also wanted to validate the clinical pain points behind these ideas.

Large-bore access spans aortic, peripheral and structural heart work, so the recruit included several…

Lost in Translation: Testing Aortic Messaging With Non-Native English Speakers

Most of the world's physicians read marketing in their second language. If a message only works for native speakers, it isn't working.

A manufacturer wanted to finalize messaging for a branch stent-graft. Foundational testing had already taken place at congress in the US. This round moved to Europe.

Interviews were held at the congress…

Three Regions, One Specialty: Sizing the Opportunity for an Endoscopic Device

How 65 hepatologists in China, the US and Europe helped size demand for a new endoscopic device.

A medical device company wanted to understand the market opportunity for a new endoscopic device used in liver disease care. It needed to know how hepatologists manage these patients today, where current tools fall short, and…

What Do Surgeons Call It? A 20-Minute, Five-Market Terminology Check

Before a launch, getting the name right matters. The question was simple: what do surgeons call it?

Ahead of a launch, a manufacturer wanted to confirm the language surgeons use for complex disease involving the visceral segment.

Each surgeon had to be actively performing endovascular aortic procedures and using the client's thoracic and abdominal…

Recruiting Nephrologists for Dialysis Access

Same specialty, neighboring markets, potentially different approaches to dialysis access.

The study set out to understand what drives nephrologists to refer patients with end-stage renal disease for a fistula, a graft, or a central venous catheter, and how much influence they have alongside surgeons and interventional radiologists.

The Netherlands and Sweden were chosen deliberately. At the planning stage, the…

Five Director-Level Neurologists: A Small, Senior, Double-Blinded Recruit

Five 45-minute, double-blind interviews with stroke department heads at US centers treating 500+ strokes a year.

A device company wanted to speak with senior US neurologists who specialize in stroke. Its own team would develop the discussion guide and moderate in English. It needed a partner to find and schedule the right physicians.

The criteria set…

Survey 104: Sizing a Niche Structural Heart Market

A two-phase study of US cardiologists paired a broad screen with a targeted survey to size demand for closing iatrogenic atrial septal defects.

A manufacturer wanted to size the market for closing iatrogenic atrial septal defects (iASDs), the small holes that can remain after transseptal procedures.

The study ran in two phases.

Phase 1 consisted of…

Picking the Right Places: Recruiting GPs by Regional Performance

Why are women in some parts of England diagnosed with ovarian cancer earlier than others?

To explore that question, the study had to compare contrasting areas. Clinical Commissioning Groups (CCGs) were ranked by the share of ovarian cancer diagnoses made at stages 1 and 2, with one-year survival as a secondary measure. Two higher-performing and…

Hearing From the Specialists: A Cross-Market Survey on Hearing Aid Satisfaction

A survey of 100 experienced ENT specialists across the US and EU5 showed a hearing technology company how satisfied hearing aid users are, which problems come up most often, and where a new device could make a difference.

A hearing technology company wanted to understand how satisfied hearing aid users are, seen through…

Two Physicians, One Decision: Why We Recruited Referrers and Implanters

To understand portal hypertension surgery uptake, you have to talk to two physicians: the one who does the surgery and the one who makes the referral.

Interventional radiologists perform the portal hypertension procedure, but hepatologists and gastroenterologists usually decide whether to refer.

This second-phase study finalized messaging for a portal hypertension device, so the…

Referrers and Implanters: Two Views of Partial-Support MCS in Europe

In advanced heart failure, the physician who implants a device is rarely the one who first sees the patient.

A company developing a partial-support mechanical circulatory support device wanted to understand how European cardiologists would view it and which patients might benefit.

The recruit targeted two distinct groups:

Heart failure cardiologists in heart centers…

Fieldwork Support for Client-Moderated Research

A medical device company planned qualitative research on interventional cardiology in Europe. Its own team would write the discussion guide and moderate every interview. What it needed was the right physicians, scheduled and ready.

The brief was 10 interventional cardiologists or electrophysiologists in Europe, all interviewed online by Zoom.

Our role covered the fieldwork end to end: Screener design…

Two Rounds, 24 Surgeons: Building Dialysis Access Messaging from the Inside Out

Build the concepts with the surgeons who know the products best, test them on everyone else, and stop once the findings settle.

A manufacturer wanted positioning and messaging for its portfolio of three dialysis access devices, presented as a single solution set.

The research used an iterative design with two rounds of…

From Congress Floor to Zoom: Recruiting 30 Vascular Physicians for Message Testing

In-person interviews shaped the language; remote follow-ups validated it.

A manufacturer preparing a lower-profile version of a balloon-expandable covered stent graft wanted to know which words and headlines would most motivate physicians treating aortoiliac occlusive disease.

The target sample was physicians who see at least 40 patients a year with aortoiliac or…

Recruiting by Device: A Balanced Sample of LAAO Physicians

Unmet needs only surface when every major device has a voice in the sample.

A manufacturer was exploring opportunities in left atrial appendage occlusion (LAAO). It wanted to understand unmet needs, market-entry considerations, and physicians' views of current devices.

The recruit targeted electrophysiologists and interventional cardiologists with at least two years post-fellowship and above-average LAAO…